Icon delivers a robust clinical trials program via our not-for-profit partner Icon Cancer Foundation [ICF]. ICF currently has 37 clinical trials open for recruitment, and has 50 active studies closed for recruitment with patients in treatment and follow-up, and over 300 patients currently on active trials across haematology, medical oncology and radiation oncology. This includes clinical trials sponsored by the pharmaceutical industry, along with collaborative studies undertaken in partnership with various universities and collaborative groups.
It is important to us that you and your loved ones are kept well informed and supported throughout the trial process. Icon Cancer Foundation employs a team of nurses, clinical trial coordinators and data managers to coordinate and manage the needs of each patient across the entire period of the trial.
Icon is dedicated to providing more access to clinical trials across our centres and help to contribute to breakthroughs and advancements in cancer treatments.